Emad Roshdy Noor

Emad Noor practices at JFK Johnson Rehab Institute - Unit in Edison, New Jersey.

Emad Noor's NPI, 1043506231, was assigned on June 25, 2011. Emad Noor holds New Jersey license 25MA09800700.

Emad Noor's primary practice is JFK Johnson Rehab Institute - Unit, at 65 James Street, Edison, NJ 08820 in Middlesex County. The practice phone is (732) 321-7000.

Emad Noor's primary practice is JFK Johnson Rehab Institute - Unit in Edison, New Jersey. Emad Noor is also affiliated with JFK University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Emad Noor to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emad Noor practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Emad Noor's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Emad Noor is licensed in New Jersey.

CMS data shows 286 Medicare services from Emad Noor across 10 procedure codes in 2024, for 184 Medicare patients. Medicare paid $22,235 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Emad Noor in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Emad Noor's median patient age at 58, with 67% women.

In 2024, Emad Noor wrote 1,339 Medicare Part D claims for 164 patients. 71% of them were for generic drugs. CMS names the drug for 1,141 of them, across 30 drugs with 11 or more claims each, at $1,928,297 in total drug cost. In 2023, CMS named 965 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Emad Noor for performance year 2024, reported as part of a group. Emad Noor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Emad Noor, published from 2022 to 2023. Emad Noor has published most often in Am J Case Rep. Emad Noor's most frequent co-authors are Abdallah Mohamed Ahmed Khashan, MD, Michael Paul Carson, MD and Haitham Dababneh, MD.

CMS Open Payments shows 434 general payments to Emad Noor from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,583.